Archives

Contents online PDF of this issue Subscribe by email This issue of HTB includes our second set of reports from the recent CROI 2019 conference. These include reports on pipeline compounds from three new classes – a maturation inhibitor, a …

First 12 reports from CROI 2019….

Early reports – updated daily… including UK patient who is second man cured of HIV

Remembering Dr Mags Portman, resistance reports, marijuana safety, new BHIVA guidelines…

Brexit, other complications and benefits of DTG/TDF/3TC in sub-Saharan Africa….

Contents online PDF of this issue Subscribe by email This last slim issue of HTB this year includes final reports from recent conferences, including HIVR4P and Glasgow 2018. We also report that doravirine and the FDC with TDF and 3TC …

Resources with Treatment Action Campaign on modern ART in Africa…

Integrase inhibitors and pregnancy, new approaches to PrEP, why U=U is not for breastfeeding and more…

Contents online PDF of this issue Subscribe by email This issue of HTB includes diverse news and reports that cover a surprising and disturbingly wide ground. Even though this was expected to be a quiet month, there is a lot …

Latest HTB online. Generic PrEP in England, UK surveillance data, AIDS 2018 reports and more…

Further reports from AIDS 2018: global health, HPV, PrEP, cure, diagnostics + more…

PARTNER2, GEMINI, dolutegravir and pregnancy, DRV/r once-daily, cure research and more

Contents online PDF of this issue Subscribe by email This HTB leads with a special report by Polly Clayden into the response to the recent safety alerts concerning dolutegravir (DTG) and its use preconception and a related article on balancing …

Simon Collins, HIV i-Base This is the second year that i-Base has produced the HIV pipeline review as part of our Fit for Purpose report on HIV treatment optimisation. Two versions will be available: 1. The full version reports key …

Contents online PDF of this issue Subscribe by email This issue of HTB starts with a treatment alert stating that cobicistat boosted darunavir is contraindicated in pregnant women. This is based on significantly reduced plasma levels of darunavir and cobicistat …

Darunavir and heart disease, a controversial review of PrEP, albuvirtide approved in China…

Third set of reports from CROI: pregnancy, adolescent care, drug interactions and side effects…

CROI reports: bictegravir, PrEP and TB reports, plus cure-related research

First reports: cure studies, new drugs for PrEP and HIV, breaking news for TB care…

Looking ahead to CROI 2018, global use of dolutegravir, challenges of being transgender and positive…